RASSU, NICOLÒ
RASSU, NICOLÒ
DMED - DIPARTIMENTO DI MEDICINA
Optic Nerve Hypoplasia, Corpus Callosum Agenesis, Cataract, and Lissencephaly in a Neonate with a Novel COL4A1 Mutation
2019-01-01 Grego, L.; Pignatto, S.; Rassu, N.; Passone, E.; Cogo, P.; Lanzetta, P.
Optical coherence tomography (OCT) and OCT angiography allow early identification of sickle cell maculopathy in children and correlate it with systemic risk factors
2020-01-01 Grego, L; Pignatto, S; Alfier, F; Arigliani, M; Rizzetto, F; Rassu, N; Samassa, F; Prosperi, R; Barbieri, F; Dall'Amico, R; Cogo, P; Lanzetta, P
Spectral-domain OCT changes in retina and optic nerve in children with hypoxic–ischaemic encephalopathy
2020-01-01 Grego, L.; Pignatto, S.; Busolini, E.; Rassu, N.; Samassa, F.; Prosperi, R.; Pittini, C.; Cattarossi, L.; Lanzetta, P.
Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO—Is there any difference? the VITDEX study
2022-01-01 Iglicki, M.; Busch, C.; Lanzetta, P.; Sarao, V.; Veritti, D.; Rassu, N.; Lupidi, M.; Cebeci, Z.; Fraser-Bell, S.; Bernal-Morales, C.; Sala-Puigdollers, A.; Zarranz-Ventura, J.; Gallego-Pinazo, R.; Maiti, A.; D'Amico Ricci, G.; Udaondo, P.; Loewenstein, A.; Chhablani, J.; Zur, D.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Optic Nerve Hypoplasia, Corpus Callosum Agenesis, Cataract, and Lissencephaly in a Neonate with a Novel COL4A1 Mutation | 1-gen-2019 | Grego, L.; Pignatto, S.; Rassu, N.; Passone, E.; Cogo, P.; Lanzetta, P. | |
| Optical coherence tomography (OCT) and OCT angiography allow early identification of sickle cell maculopathy in children and correlate it with systemic risk factors | 1-gen-2020 | Grego, L; Pignatto, S; Alfier, F; Arigliani, M; Rizzetto, F; Rassu, N; Samassa, F; Prosperi, R; Barbieri, F; Dall'Amico, R; Cogo, P; Lanzetta, P | |
| Spectral-domain OCT changes in retina and optic nerve in children with hypoxic–ischaemic encephalopathy | 1-gen-2020 | Grego, L.; Pignatto, S.; Busolini, E.; Rassu, N.; Samassa, F.; Prosperi, R.; Pittini, C.; Cattarossi, L.; Lanzetta, P. | |
| Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO—Is there any difference? the VITDEX study | 1-gen-2022 | Iglicki, M.; Busch, C.; Lanzetta, P.; Sarao, V.; Veritti, D.; Rassu, N.; Lupidi, M.; Cebeci, Z.; Fraser-Bell, S.; Bernal-Morales, C.; Sala-Puigdollers, A.; Zarranz-Ventura, J.; Gallego-Pinazo, R.; Maiti, A.; D'Amico Ricci, G.; Udaondo, P.; Loewenstein, A.; Chhablani, J.; Zur, D. |